leucine methyl ester has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreesen, R; Konur, A; Krause, SW; Kreutz, M; Rehli, M | 1 |
| Mizutani, Y; Nio, Y; Yoshida, O | 1 |
2 other study(ies) available for leucine methyl ester and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide.
Topics: Arginine; Carcinoma, Transitional Cell; Coculture Techniques; Drug Combinations; Humans; Interleukin-1; Kidney Medulla; Leucine; Macrophage Activation; Monocytes; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Solubility; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1996 |
Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cell Line; Chloroquine; Cisplatin; Cytotoxicity, Immunologic; Female; Humans; Killer Cells, Lymphokine-Activated; Leucine; Lymphocytes; Male; Middle Aged; Mitomycin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1992 |